Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.58 USD
Change Today +0.2173 / 1.63%
Volume 2.4M
ZIOP On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:08 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

ziopharm oncology inc (ZIOP) Snapshot

Open
$13.31
Previous Close
$13.36
Day High
$14.00
Day Low
$13.31
52 Week High
03/20/15 - $14.40
52 Week Low
10/8/14 - $2.31
Market Cap
1.7B
Average Volume 10 Days
3.0M
EPS TTM
$-0.31
Shares Outstanding
128.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZIOPHARM ONCOLOGY INC (ZIOP)

ziopharm oncology inc (ZIOP) Related Bloomberg News

View More Bloomberg News

ziopharm oncology inc (ZIOP) Related Businessweek News

No Related Businessweek News Found

ziopharm oncology inc (ZIOP) Details

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in collaboration with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability. The company is also developing programs in various stages of development together with Intrexon Corporation's RheoSwitch Therapeutic System(r) technology, a switch to turn on and off, and precisely modulate, gene expression in order to improve therapeutic index. Its pipeline includes various gene and cell-based therapeutics in both clinical and preclinical testing which are focused on hematologic and solid tumor malignancies. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts.

27 Employees
Last Reported Date: 02/26/15
Founded in 2003

ziopharm oncology inc (ZIOP) Top Compensated Officers

Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $238.7K
Chief Operating Officer, Chief Legal Officer,...
Total Annual Compensation: $472.5K
Compensation as of Fiscal Year 2014.

ziopharm oncology inc (ZIOP) Key Developments

ZIOPHARM Oncology, Inc. Appoints Caesar J. Belbel as Chief Operating Officer

ZIOPHARM Oncology, Inc. announced that Caesar J. Belbel, Executive Vice President, Chief Legal Officer and Secretary, has been appointed to the added role of Chief Operating Officer, effective immediately.

ZIOPHARM Oncology, Inc. Announces Director Change

ZIOPHARM Oncology, Inc. announced that Timothy McInerney, who has served as a director since 2005, was not nominated for re-election and his term as a director will expire at the annual meeting.

ZIOPHARM Oncology, Inc. Announces Resignation of Jonathan Lewis as from the Board of Directors

On May 11, 2015, Jonathan Lewis, M.D., Ph.D. notified ZIOPHARM Oncology, Inc., or the company, of his decision to resign effective immediately and not to stand for re-election at the company's 2015 Annual Meeting of Stockholders. The company's board of directors has determined not to nominate a new nominee for election at the Annual Meeting to fill the vacancy created by Dr. Lewis' resignation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZIOP:US $13.58 USD +0.2173

ZIOP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aduro Biotech Inc $25.40 USD -0.82
Advaxis Inc $15.91 USD -0.75
Dynavax Technologies Corp $29.95 USD +0.54
Exact Sciences Corp $23.93 USD -0.14
Genocea Biosciences Inc $13.10 USD +0.10
View Industry Companies
 

Industry Analysis

ZIOP

Industry Average

Valuation ZIOP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,048.6x
Price/Book 14.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,095.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIOPHARM ONCOLOGY INC, please visit www.ziopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.